Scherle Peggy's Form 4 filing
Prelude Therapeutics Inc (PRLD) · filed Aug 17, 2021
- Accession no.
- 0001209191-21-051885
- Filed
- Aug 17, 2021
- Trade date
- Aug 13, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $80.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scherle PeggyCIK 0001824632 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Common Stock | MOption exerciseAcquired | +558 | $1.89 | +$1,054.62 | 173,478 | Direct | |
| Aug 13, 2021 | Common Stock | MOption exerciseAcquired | +1,728 | $1.43 | +$2,471.04 | 175,206 | Direct | |
| Aug 13, 2021 | Common Stock | SSaleDisposed | −2,286 | $35.07 | −$80,170.02 | 172,920 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Common Stock | MOption exerciseDisposed | −558 | $0.00 | $0 | 42,672 | Direct | |
| Aug 13, 2021 | Common Stock | MOption exerciseDisposed | −1,728 | $0.00 | $0 | 34,732 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.